Literature DB >> 20139719

Mitogen activated protein kinase phosphatases and cancer.

Kelly K Haagenson1, Gen Sheng Wu.   

Abstract

Deregulation of cell signaling is a vital part of cancer development. The mitogen activated protein kinase (MAPK) family is involved in regulating both cell growth and cell death. This family of kinases is negatively regulated by mitogen activated protein kinase phosphatases (MKPs). MKPs are dual specificity phosphatases that target threonine and tyrosine residues that appear in a TXY motif. There are eleven members of the MKP family. Expression of MKPs has been shown to be altered in many different types of cancer. Most of what is known centers on MKP-1, MKP-2 and MKP-3. This review will focus on their role in cancer development and progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20139719      PMCID: PMC4063278          DOI: 10.4161/cbt.9.5.11217

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  33 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  The dual-specificity protein phosphatase DUSP9/MKP-4 is essential for placental function but is not required for normal embryonic development.

Authors:  Graham R Christie; David J Williams; Fiona Macisaac; Robin J Dickinson; Ian Rosewell; Stephen M Keyse
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

3.  Mitogen-activated protein kinase phosphatase-1 is required for cisplatin resistance.

Authors:  Zhaoqing Wang; Jing Xu; Jun-Ying Zhou; Yusen Liu; Gen Sheng Wu
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

4.  Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance.

Authors:  Yukun Cui; Irma Parra; Mao Zhang; Susan G Hilsenbeck; Anna Tsimelzon; Toru Furukawa; Akira Horii; Zhong-Yin Zhang; Robert I Nicholson; Suzanne A W Fuqua
Journal:  Cancer Res       Date:  2006-06-01       Impact factor: 12.701

Review 5.  Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer.

Authors:  Gen Sheng Wu
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

6.  The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death.

Authors:  Jun-Ying Zhou; Yusen Liu; Gen Sheng Wu
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

7.  Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance.

Authors:  George W Small; Yue Y Shi; Linda S Higgins; Robert Z Orlowski
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

8.  Microtubule disruption and tumor suppression by mitogen-activated protein kinase phosphatase 4.

Authors:  Yuangang Liu; James Lagowski; Aaron Sundholm; Alexandra Sundberg; Molly Kulesz-Martin
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

9.  Structurally unique inhibitors of human mitogen-activated protein kinase phosphatase-1 identified in a pyrrole carboxamide library.

Authors:  John S Lazo; John J Skoko; Stefan Werner; Branko Mitasev; Ahmet Bakan; Fumito Koizumi; Archibong Yellow-Duke; Ivet Bahar; Kay M Brummond
Journal:  J Pharmacol Exp Ther       Date:  2007-05-30       Impact factor: 4.030

10.  ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cells.

Authors:  Juan Wang; Jun-Ying Zhou; Gen Sheng Wu
Journal:  Cancer Res       Date:  2007-12-15       Impact factor: 12.701

View more
  28 in total

1.  Prospero homeobox 1 mediates the progression of gastric cancer by inducing tumor cell proliferation and lymphangiogenesis.

Authors:  Kang-Jin Park; Sung-Bum Cho; Young-Lan Park; Nuri Kim; Sun-Young Park; Dae-Seong Myung; Wan-Sik Lee; Sun-Seog Kweon; Young-Eun Joo
Journal:  Gastric Cancer       Date:  2016-01-12       Impact factor: 7.370

2.  Myeloid cell leukemia-1 is associated with tumor progression by inhibiting apoptosis and enhancing angiogenesis in colorectal cancer.

Authors:  Wan-Sik Lee; Young-Lan Park; Nuri Kim; Hyung-Hoon Oh; Dong-Jun Son; Mi-Young Kim; Chan-Young Oak; Cho-Yun Chung; Hyung-Chul Park; Jong-Sun Kim; Dae-Seong Myung; Sung-Bum Cho; Hyun-Soo Kim; Young-Eun Joo
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

3.  Procyanidin B2 3,3″-di-O-gallate induces oxidative stress-mediated cell death in prostate cancer cells via inhibiting MAP kinase phosphatase activity and activating ERK1/2 and AMPK.

Authors:  Rahul Kumar; Gagan Deep; Michael F Wempe; Joseph Surek; Amit Kumar; Rajesh Agarwal; Chapla Agarwal
Journal:  Mol Carcinog       Date:  2017-09-22       Impact factor: 4.784

4.  Giganteaside D induces ROS-mediated apoptosis in human hepatocellular carcinoma cells through the MAPK pathway.

Authors:  Junshan Liu; Xiduan Wei; Yafeng Wu; Yanni Wang; Yuwen Qiu; Junmin Shi; Hongling Zhou; Zibin Lu; Meng Shao; Linzhong Yu; Li Tong
Journal:  Cell Oncol (Dordr)       Date:  2016-03-25       Impact factor: 6.730

5.  Proteome Analysis of Hypoxic Glioblastoma Cells Reveals Sequential Metabolic Adaptation of One-Carbon Metabolic Pathways.

Authors:  Kangling Zhang; Pei Xu; James L Sowers; Daniel F Machuca; Barsam Mirfattah; Jason Herring; Hui Tang; Yan Chen; Bing Tian; Allan R Brasier; Lawrence C Sowers
Journal:  Mol Cell Proteomics       Date:  2017-09-05       Impact factor: 5.911

6.  Luteolin and sorafenib combination kills human hepatocellular carcinoma cells through apoptosis potentiation and JNK activation.

Authors:  Xu-Qin Feng; Li-Wen Rong; Rui-Xue Wang; Xue-Lian Zheng; Lei Zhang; Lin Zhang; Yong Lin; Xia Wang; Zhi-Ping Li
Journal:  Oncol Lett       Date:  2018-05-04       Impact factor: 2.967

7.  Integrated analyses of genome-wide DNA occupancy and expression profiling identify key genes and pathways involved in cellular transformation by a Marek's disease virus oncoprotein, Meq.

Authors:  Sugalesini Subramaniam; John Johnston; Likit Preeyanon; C Titus Brown; Hsing-Jien Kung; Hans H Cheng
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

Review 8.  The impact of phosphatases on proliferative and survival signaling in cancer.

Authors:  Goutham Narla; Jaya Sangodkar; Christopher B Ryder
Journal:  Cell Mol Life Sci       Date:  2018-05-03       Impact factor: 9.261

9.  Decreased expression and prognostic role of mitogen-activated protein kinase phosphatase 4 in hepatocellular carcinoma.

Authors:  Jinxia Liu; Wenkai Ni; Mingbing Xiao; Feng Jiang; Runzhou Ni
Journal:  J Gastrointest Surg       Date:  2013-01-17       Impact factor: 3.452

10.  MAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition.

Authors:  David M Taylor; Roger Moser; Etienne Régulier; Lionel Breuillaud; Meredith Dixon; Ayshe Ana Beesen; Linda Elliston; Mariana de Fatima Silva Santos; Jinho Kim; Lesley Jones; Darlene R Goldstein; Robert J Ferrante; Ruth Luthi-Carter
Journal:  J Neurosci       Date:  2013-02-06       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.